Zhao-Xue Yu

2.4k total citations
15 papers, 1.9k citations indexed

About

Zhao-Xue Yu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Zhao-Xue Yu has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Immunology. Recurrent topics in Zhao-Xue Yu's work include Mitochondrial Function and Pathology (5 papers), Genetic Neurodegenerative Diseases (5 papers) and Complement system in diseases (4 papers). Zhao-Xue Yu is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Genetic Neurodegenerative Diseases (5 papers) and Complement system in diseases (4 papers). Zhao-Xue Yu collaborates with scholars based in United States, United Kingdom and China. Zhao-Xue Yu's co-authors include Xiao‐Jiang Li, Shihua Li, Li He, Zhihui Fang, Chuan-En Wang, Shihua Li, Ji‐Yeon Shin, Xiaojiang Li, Peggy Shelbourne and Ajay Pillarisetti and has published in prestigious journals such as Nature, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Zhao-Xue Yu

15 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhao-Xue Yu United States 12 1.2k 1.1k 417 270 267 15 1.9k
Satoko Miyatake Japan 29 1.5k 1.2× 508 0.5× 195 0.5× 142 0.5× 132 0.5× 146 2.4k
Jonathan Baets Belgium 26 1.1k 0.9× 1.1k 1.0× 324 0.8× 234 0.9× 113 0.4× 80 2.2k
Nestor X. Barrezueta United States 13 614 0.5× 494 0.5× 86 0.2× 256 0.9× 107 0.4× 14 1.3k
Jun Mitsui Japan 24 860 0.7× 480 0.4× 582 1.4× 230 0.9× 37 0.1× 115 1.7k
Hiroyuki Ishiura Japan 25 844 0.7× 633 0.6× 627 1.5× 145 0.5× 35 0.1× 146 1.8k
Toshio Masuzawa Japan 23 635 0.5× 502 0.5× 318 0.8× 132 0.5× 115 0.4× 97 1.7k
Wang Zheng China 21 721 0.6× 343 0.3× 136 0.3× 122 0.5× 108 0.4× 43 1.5k
Galina Dvoriantchikova United States 26 1.1k 0.9× 260 0.2× 128 0.3× 219 0.8× 300 1.1× 52 1.9k
Nicoleta Moisoi United Kingdom 14 973 0.8× 295 0.3× 561 1.3× 250 0.9× 83 0.3× 29 1.6k
Wendy Hobbs United States 11 924 0.8× 850 0.8× 749 1.8× 187 0.7× 64 0.2× 17 1.9k

Countries citing papers authored by Zhao-Xue Yu

Since Specialization
Citations

This map shows the geographic impact of Zhao-Xue Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao-Xue Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao-Xue Yu more than expected).

Fields of papers citing papers by Zhao-Xue Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao-Xue Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao-Xue Yu. The network helps show where Zhao-Xue Yu may publish in the future.

Co-authorship network of co-authors of Zhao-Xue Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao-Xue Yu. A scholar is included among the top collaborators of Zhao-Xue Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao-Xue Yu. Zhao-Xue Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Liu, Jia, Jie Lan, Zhao-Xue Yu, et al.. (2023). Targeting hypoxia-induced CBS expression inhibits breast cancer stem cells through the induction of ferroptosis. Genes & Diseases. 10(6). 2195–2198. 1 indexed citations
2.
Hu, Yuting, Lei Zhao, Yujie Liu, Hui Li, & Zhao-Xue Yu. (2021). Abstract 496: Humanized SIRPA and double humanized SIRPA/CD47 B-NDG mouse models are promising tools for anti-SIRPα antibody in vivo efficacy studies. Cancer Research. 81(13_Supplement). 496–496. 1 indexed citations
3.
Sheridan, Douglas, Zhao-Xue Yu, Yuchun Zhang, et al.. (2018). Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action. PLoS ONE. 13(4). e0195909–e0195909. 177 indexed citations
4.
Rich, Megan, Miriam D. Neher, Krista Johnson, et al.. (2016). Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains. Neuroscience Letters. 617. 188–194. 34 indexed citations
5.
Sheridan, Douglas, Zhao-Xue Yu, Yuchun Zhang, et al.. (2016). Design and preclinical characterization of ALXN1210: A next generation anti-C5 monoclonal antibody with improved pharmacokinetics and duration of action. Immunobiology. 221(10). 1158–1158. 6 indexed citations
7.
Ruseva, Marieta M., Tao Peng, Melissa A. Lasaro, et al.. (2015). Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy. Journal of the American Society of Nephrology. 27(2). 405–416. 24 indexed citations
8.
Sheng, Guoqing, Guo‐Qing Chang, John Y. Lin, et al.. (2006). Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nature Medicine. 12(5). 526–533. 80 indexed citations
9.
Kim, Mina, Zhao-Xue Yu, Bertil B. Fredholm, & Scott A. Rivkees. (2005). Susceptibility of the developing brain to acute hypoglycemia involving A1adenosine receptor activation. American Journal of Physiology-Endocrinology and Metabolism. 289(4). E562–E569. 36 indexed citations
10.
Shin, Ji‐Yeon, Zhihui Fang, Zhao-Xue Yu, et al.. (2005). Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. The Journal of Cell Biology. 171(6). 1001–1012. 365 indexed citations
11.
Li, Shihua, Zhao-Xue Yu, Cui-Lin Li, et al.. (2003). Lack of Huntingtin-Associated Protein-1 Causes Neuronal Death Resembling Hypothalamic Degeneration in Huntington's Disease. Journal of Neuroscience. 23(17). 6956–6964. 118 indexed citations
12.
Liou, Yih‐Cherng, Anyang Sun, Akihide Ryo, et al.. (2003). Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature. 424(6948). 556–561. 365 indexed citations
13.
Zhou, Hui, Fengli Cao, Zhishan Wang, et al.. (2003). Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. The Journal of Cell Biology. 163(1). 109–118. 135 indexed citations
14.
Yu, Zhao-Xue, et al.. (2003). Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease. Journal of Neuroscience. 23(6). 2193–2202. 213 indexed citations
15.
He, Li, Shihua Li, Zhao-Xue Yu, Peggy Shelbourne, & Xiaojiang Li. (2001). Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice. Journal of Neuroscience. 21(21). 8473–8481. 294 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026